Pacific Biosciences of California Inc. buy Stephens
Start price
10.11.25
/
50%
€1.56
Target price
10.11.26
€1.73
Performance (%)
15.82%
Price
12.12.25
€1.81
Summary
This prediction is currently active. The prediction currently has a performance of 15.82%. This prediction currently runs until 10.11.26. The prediction end date can be changed by Stephens at any time. Stephens has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | -11.998% | -11.998% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Stephens for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California (NASDAQ:PACB) had its price target raised by analysts at Stephens from $1.80 to $2.00. They now have an "overweight" rating on the stock.
Ratings data for PACB provided by MarketBeat
Stopped prediction by Stephens for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€0.94
15.05.25
15.05.25
€1.61
15.05.26
15.05.26
92.84%
12.12.25
12.12.25
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.61
14.02.25
14.02.25
€2.38
14.02.26
14.02.26
12.73%
12.12.25
12.12.25
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€8.42
14.12.23
14.12.23
€10.05
14.12.24
14.12.24
-77.24%
15.12.24
15.12.24